Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells

被引:10
作者
Bae, CD
Juhnn, YS
Park, JB
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Kyungkido, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 110799, South Korea
关键词
c-erb B-2; oncogene; overexpression; stomach cancer;
D O I
10.1038/emm.2001.3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growth factor receptor oncogene, c-erb B-2, is frequently overexpressed in the adenocarcinomas of breast, ovary, lung and stomach. Although the mechanism of erb B-2 overexpression is thought as the result of transcriptional upregulation in many primary human carcinomas, expression rate of c-erb B-2 at mRNA level is usually lower than the level of translated protein. We also found that the expression of erb 8-2 in SNU-1 stomach cancer cells was greater at post-transcription level (Bae et al, 1993), To explore the underlying mechanism of erb 8-2 protein overexpression, we have chosen two cells lines, SNU-1 and SNU-16 where transcription rate of erb B-2 was closely resemble to each other while expressed protein levels were quite different. The synthesis rate of erb B-2 protein in SNU-1 cells was faster than SNU-16 cells while levels of erb B-2 mRNA were found to be similar in both cell lines. The half-life of the expressed erb B-2 protein was not significantly different in both cell lines. Analysis of the 5' untranslated region (UTR) of erb B-2 mRNA (-1 similar to -323) showed no sequence abnormality in both cell lines. However, ribonuclease protection assay using cloned 5 UTR sequence revealed that the size of 5' UTR of erb B-2 mRNA which associate with transcription initiation site(s) in SNU-1 cells was longer than that in SNU-16. These results suggest that the increased erb B-2 protein synthesis rate possibly due to the redundant selection of transcription initiation might be a mechanism of erb B-2 overexpression in SNU-1 cells.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 14 条
[1]  
Bae CD, 1996, MOL CELLS, V6, P101
[2]  
Bae Chang-Dae, 1993, Journal of Korean Medical Science, V8, P153
[3]   THE RECEPTOR TYROSINE KINASE P185(HER2) IS EXPRESSED ON A SUBSET OF B-LYMPHOID BLASTS FROM PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND CHRONIC MYELOGENOUS LEUKEMIA [J].
BUHRING, HJ ;
SURES, I ;
JALLAL, B ;
WEISS, FU ;
BUSCH, FW ;
LUDWIG, WD ;
HANDGRETINGER, R ;
WALLER, HD ;
ULLRICH, A .
BLOOD, 1995, 86 (05) :1916-1923
[4]   Translational control by an upstream open reading frame in the HER-2/neu transcript [J].
Child, SJ ;
Miller, MK ;
Geballe, AP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (34) :24335-24341
[5]  
GROOTECLAES M, 1994, CANCER RES, V54, P4193
[6]  
HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441
[7]  
OSHIMA M, 1995, J NEUROCHEM, V65, P427
[8]  
PARK JB, 1989, CANCER RES, V49, P6605
[9]   STUDIES OF THE HER-2/NEU PROTO-ONCOGENE IN HUMAN-BREAST AND OVARIAN-CANCER [J].
SLAMON, DJ ;
GODOLPHIN, W ;
JONES, LA ;
HOLT, JA ;
WONG, SG ;
KEITH, DE ;
LEVIN, WJ ;
STUART, SG ;
UDOVE, J ;
ULLRICH, A ;
PRESS, MF .
SCIENCE, 1989, 244 (4905) :707-712
[10]   HUMAN-BREAST CANCER - CORRELATION OF RELAPSE AND SURVIVAL WITH AMPLIFICATION OF THE HER-2 NEU ONCOGENE [J].
SLAMON, DJ ;
CLARK, GM ;
WONG, SG ;
LEVIN, WJ ;
ULLRICH, A ;
MCGUIRE, WL .
SCIENCE, 1987, 235 (4785) :177-182